Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityDividends payablesLiabilities and Shareholders EquityLoans - GrossLoans - Loss AllowanceLoans - NetMortgage LoansNon-Current DebtPayablesPrepaid AssetsReceivables - AccuredRetained EarningsShareholder's EquityTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Ratios

Advanced Flower Capital (AFCG) Liabilities and Shareholders Equity (2022 - 2025)

Historic Liabilities and Shareholders Equity for Advanced Flower Capital (AFCG) over the last 4 years, with Q3 2025 value amounting to $288.7 million.

  • Advanced Flower Capital's Liabilities and Shareholders Equity fell 2124.86% to $288.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year decrease of 2628.32%. This contributed to the annual value of $402.1 million for FY2024, which is 1382.98% down from last year.
  • As of Q3 2025, Advanced Flower Capital's Liabilities and Shareholders Equity stood at $288.7 million, which was down 2124.86% from $290.6 million recorded in Q2 2025.
  • Over the past 5 years, Advanced Flower Capital's Liabilities and Shareholders Equity peaked at $519.2 million during Q4 2022, and registered a low of $288.7 million during Q3 2025.
  • For the 4-year period, Advanced Flower Capital's Liabilities and Shareholders Equity averaged around $421.4 million, with its median value being $454.0 million (2023).
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first surged by 638.01% in 2024, then crashed by 3655.13% in 2025.
  • Over the past 4 years, Advanced Flower Capital's Liabilities and Shareholders Equity (Quarter) stood at $519.2 million in 2022, then decreased by 10.13% to $466.6 million in 2023, then decreased by 13.83% to $402.1 million in 2024, then fell by 28.19% to $288.7 million in 2025.
  • Its Liabilities and Shareholders Equity stands at $288.7 million for Q3 2025, versus $290.6 million for Q2 2025 and $321.7 million for Q1 2025.